2017
Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature
CHOVANCOVÁ, Zita, Pavlina KRALICKOVA, Alena PEJCHALOVÁ, Marketa BLOOMFIELD, Jana NECHVÁTALOVÁ et. al.Základní údaje
Originální název
Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature
Autoři
CHOVANCOVÁ, Zita (203 Česká republika, garant, domácí), Pavlina KRALICKOVA (203 Česká republika), Alena PEJCHALOVÁ (203 Česká republika), Marketa BLOOMFIELD (203 Česká republika), Jana NECHVÁTALOVÁ (203 Česká republika, domácí), Marcela VLKOVÁ (203 Česká republika, domácí) a Jiří LITZMAN (203 Česká republika, domácí)
Vydání
Journal of Clinical Immunology, New York, Springer, 2017, 0271-9142
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30102 Immunology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 4.227
Kód RIV
RIV/00216224:14110/17:00098289
Organizační jednotka
Lékařská fakulta
UT WoS
000407597600011
Klíčová slova anglicky
Selective IgM deficiency; primary immunodeficiency; infections; autoimmunity; allergy
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 7. 3. 2018 16:08, Soňa Böhmová
Anotace
V originále
Primary selective IgM deficiency (sIgMD) is a primary immunodeficiency with unclear pathogenesis and a low number of published cases. We reviewed clinical and laboratory manifestations of 17 sIgMD patients. Serum IgM, IgG, and its subclasses, IgA, IgE, antibodies against tetanus toxoid, pneumococcal polysaccharides and Haemophilus influenzae type b, isohemagglutinins, and T and B lymphocyte subsets, expressions of IgM on B cells and B lymphocyte production of IgM were compared with previously reported case reports and a small series of patients, which included 81 subjects in total. We found that some patients in our cohort (OC) and published cases (PC) had increased IgE levels (OC 7/15; PC 21/37), decreased IgG4 levels (OC 5/14), very low titers of isohemagglutinins (OC 8/8; PC 18/21), increased transitional B cell counts (OC 8/9), decreased marginal zone B cell counts (OC 8/9), and increased 21(low) B cell counts (OC 7/9). Compared with the PC (20/20), only two of five OC patients showed very low or undetectable production of IgM after stimulation. A majority of the patients had normal antibody production to protein and polysaccharide antigens, basic lymphocyte subset counts, and expression of surface IgM molecules on B cells. Low IgM levels are associated with various immunopathological disorders; however, pathogenic mechanisms leading to decreased IgM serum level in selective IgM deficiency remain unclear. Moreover, it is difficult to elucidate how strong these associations are and if these immunopathological conditions are primary or secondary.